SEC Form 4 · accession 0001209191-18-010955
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorma Routti
Director
Period of report
Feb 14, 2018
Accepted (ET)
Feb 16, 2018 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 14, 2018 | M | 6,000 | $3.50 | A | 133,840 | D | |
| Common StockF1,F2 | Feb 14, 2018 | S | 1,193 | $53.77 | D | 132,647 | D | |
| Common StockF1,F3 | Feb 14, 2018 | S | 1,907 | $54.62 | D | 130,740 | D | |
| Common StockF1,F4 | Feb 14, 2018 | S | 2,900 | $55.50 | D | 127,840 | D | |
| Common Stock | Feb 15, 2018 | M | 6,000 | $3.50 | A | 133,840 | D | |
| Common StockF1,F5 | Feb 15, 2018 | S | 4,600 | $55.55 | D | 129,240 | D | |
| Common StockF1,F6 | Feb 15, 2018 | S | 1,400 | $56.27 | D | 127,840 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F7 | $3.50 | Feb 14, 2018 | M | 6,000 | D | — | Mar 15, 2021 | Common Stock | 6,000 | 6,000 | D |
| Stock Option (Right to Buy)F7 | $3.50 | Feb 15, 2018 | M | 6,000 | D | — | Mar 15, 2021 | Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2The shares were sold at prices ranging from $53.20 to $54.175. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The shares were sold at prices ranging from $54.20 to $55.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The shares were sold at prices ranging from $55.30 to $55.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The shares were sold at prices ranging from $55.00 to $55.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The shares were sold at prices ranging from $56.05 to $56.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7Fully vested.